UK markets closed

Denali Therapeutics Inc. (DNLI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
24.10+0.01 (+0.04%)
At close: 04:00PM EDT
24.10 0.00 (0.00%)
After hours: 04:01PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
295,390
330,531
108,463
48,661
335,659
-
Operating expenses
Research development
402,076
423,876
358,732
265,353
212,615
-
Selling general and administrative
101,450
103,354
90,475
79,059
60,326
-
Total operating expenses
503,526
527,230
449,207
344,412
272,941
-
Operating income or loss
-208,136
-196,699
-340,744
-295,751
62,718
-
Income before tax
-137,215
-145,194
-325,970
-291,156
71,959
-
Income tax expense
-
30
21
-575
823
-
Income from continuing operations
-137,245
-145,224
-325,991
-290,581
71,136
-
Net income
-137,245
-145,224
-325,991
-290,581
71,136
-
Net income available to common shareholders
-137,245
-145,224
-325,991
-290,581
71,136
-
Basic EPS
-0.94
-
-2.60
-2.39
0.65
-2.07
Diluted EPS
-0.94
-
-2.60
-2.39
0.63
-2.07
Basic average shares
136,047
-
125,531
121,525
108,974
95,608
Diluted average shares
136,047
-
125,531
121,525
112,703
95,608